Views & Analysis LHON in the family: living under the spectre of an hereditar... It’s hard to imagine suddenly losing your sight in your 20s, but that’s what happened to Richard Wheeler when he developed
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends